A Deadly Epidemic

9.One company made a genetic test claiming to spot addiction before it hits. Then it was raided by the FBI.

Another company seeking to profit off the opioid epidemic was Proove Biosciences, which touted personalized DNA tests meant to help select pain medications least likely to lead to addiction for each patient. The only problem? It was backed by almost no scientific data showing how reliable the tests were.

And it paid doctors up to $ 144,000 a year in “research fees” to get results for a clinical trial to prove its effectiveness, according to an investigation by STAT News.

That is, until June of 2017, when 25 FBI agents raided the California-based lab and hauled away boxes of documents as a part of a health care fraud investigation.

Got a confidential tip? Submit it here.